View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/SAMHSA RIN: 0930-AA25 Publication ID: Fall 2016 
Title: ●Medication Assisted Treatment for Opioid Use Disorders--Nurse Practitioners and Physician Assistants 
Abstract:

On July 8, 2016, SAMHSA finalized a rule to increase access to buprenorphine and the combination buprenorphine/naloxone (Medication Assisted Treatment for Opioid Use Disorders) allowing physicians prescribing buprenorphine to treat up to 275 patients. This Notice of Proposed Rulemaking would implement aspects of section 303 of the Comprehensive Addiction Recovery Act by establishing the criteria for Nurse Practitioners and Physicians Assistants to obtain a waiver to treat up to 100 patients.

 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Undetermined  Unfunded Mandates: Undetermined 
EO 13771 Designation: uncollected 
CFR Citation: 42 CFR 8   
Legal Authority: 21 U.S.C. 823(g)(2)(G)(iv)   
Legal Deadline:
Action Source Description Date
Final  Statutory  Deadline per section 303 of the CARA  01/22/2018 
Timetable:
Action Date FR Cite
NPRM  07/00/2017 
Final Action  01/00/2018 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Undetermined 
Federalism: Undetermined 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Related RINs: Related to 0930-AA22 
Agency Contact:
Brian Altman
Legislative Director
Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road,
Rockville, MD 02857
Phone:240 276-2009
Email: brian.altman@samhsa.gov